Microalbuminuria is diagnosed:
- excretion of 30–300 mg of albumin/24 h
- or 20–200 µg/min or 30–300 µg/mg of creatinine on two of three urine collections
- Abid O, Sun Q, Sugimoto K, et al. Predictive value of microalbuminuria in medical ICU patients. Chest. 2001;120:1984-1988.
- Lievre M, Marre M, Chatellier G, Plouin P, Reglier J, Richardson L et al. The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and rampiril (DIABHYCAR) study : design, organization, and patients recruitment. DIABHYCAR Study Group. Controlled Clinical Trials 2000; 21: 383-96.
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators comments . Lancet 2000;355:253-9
- Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD. Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney International 2000;58: 2129-37
- Lemley KV, Abdullah I, Myers BD, Meyer TW, Blouch K, Smith WE et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney International 2000;58:1228-37.
- Parving HH, Lenher H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P et al The effect of irbesartan on the development of diabetic nephropathy in patients with Type 2 diabetes. comments . New England Journal of Medicine 2001;345:870-8.
|
